Home | Contact | The Innovative Medicines Initiative   



Scientific Aims and Objectives of AddNeuroMed

The AddNeuroMed objectives are to:
  • Produce improve experimental models of Alzheimer's for biomarker discovery
  • Identify a biomarker for Alzheimer's disease suitable for
    • Diagnosis, especially early diagnosis
    • Prediction, in particular helping to identify those people with mild cognitive impairment at increased risk of developing dementia
    • Monitoring disease progression for use in clinical trials and in clinical practice

More details

Public Aims and Objectives of AddNeuroMed

The overall aim of AddNeuroMed is to find a biomarker for Alzheimer's disease. A biomarker is a test that can be used to help diagnose a condition or to help monitor a condition or response to treatment. Biomarkers are used in many areas of medicine both in ordinary medical practice and also in research, especially in clinical trials.
More details

AddNeuroMed, as part of InnoMed, is a precursor of the Innovative Medicines Initiative
Home | Contact | Disclaimer | Privacy